NDC 50181-0041 Neurobalance Pro
Adrenocorticotrophin,Gaba,Glutamic Acid,Norepinephrine,Acetylcholine - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Get all the details for National Drug Code (NDC) 50181-0041 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.
Code Structure Chart
Product Details
What is NDC 50181-0041?
What are the uses for Neurobalance Pro?
What are Neurobalance Pro Active Ingredients?
- .GAMMA.-AMINOBUTYRIC ACID 6 [hp_X]/mL - The most common inhibitory neurotransmitter in the central nervous system.
- ACETYLCHOLINE CHLORIDE 6 [hp_X]/mL - A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
- BARIUM CARBONATE 6 [hp_C]/mL
- CORTICOTROPIN 6 [hp_X]/mL
- DATURA STRAMONIUM 30 [hp_C]/mL - A plant species of the genus DATURA, family SOLANACEAE, that contains TROPANES and other SOLANACEOUS ALKALOIDS.
- EPINEPHRINE 6 [hp_X]/mL - The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.
- GLUTAMIC ACID 6 [hp_X]/mL - A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.
- LEVODOPA 6 [hp_X]/mL - The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.
- NOREPINEPHRINE 6 [hp_X]/mL - Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic.
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_C]/mL
- SEMECARPUS ANACARDIUM JUICE 6 [hp_C]/mL
- SEROTONIN HYDROCHLORIDE 6 [hp_X]/mL
- THYROID 6 [hp_X]/mL - A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.
Which are Neurobalance Pro UNII Codes?
The UNII codes for the active ingredients in this product are:
- CORTICOTROPIN (UNII: K0U68Q2TXA)
- CORTICOTROPIN (UNII: K0U68Q2TXA) (Active Moiety)
- .GAMMA.-AMINOBUTYRIC ACID (UNII: 2ACZ6IPC6I)
- .GAMMA.-AMINOBUTYRIC ACID (UNII: 2ACZ6IPC6I) (Active Moiety)
- GLUTAMIC ACID (UNII: 3KX376GY7L)
- GLUTAMIC ACID (UNII: 3KX376GY7L) (Active Moiety)
- NOREPINEPHRINE (UNII: X4W3ENH1CV)
- NOREPINEPHRINE (UNII: X4W3ENH1CV) (Active Moiety)
- ACETYLCHOLINE CHLORIDE (UNII: AF73293C2R)
- ACETYLCHOLINE (UNII: N9YNS0M02X) (Active Moiety)
- EPINEPHRINE (UNII: YKH834O4BH)
- EPINEPHRINE (UNII: YKH834O4BH) (Active Moiety)
- LEVODOPA (UNII: 46627O600J)
- LEVODOPA (UNII: 46627O600J) (Active Moiety)
- SEROTONIN HYDROCHLORIDE (UNII: GKN429M9VS)
- SEROTONIN (UNII: 333DO1RDJY) (Active Moiety)
- THYROID, PORCINE (UNII: 6RV024OAUQ)
- SUS SCROFA THYROID (UNII: 6RV024OAUQ) (Active Moiety)
- SEMECARPUS ANACARDIUM JUICE (UNII: Y0F0BU8RDU)
- SEMECARPUS ANACARDIUM JUICE (UNII: Y0F0BU8RDU) (Active Moiety)
- BARIUM CARBONATE (UNII: 6P669D8HQ8)
- BARIUM CATION (UNII: V645272HLN) (Active Moiety)
- OYSTER SHELL CALCIUM CARBONATE, CRUDE (UNII: 2E32821G6I)
- OYSTER SHELL CALCIUM CARBONATE, CRUDE (UNII: 2E32821G6I) (Active Moiety)
- DATURA STRAMONIUM (UNII: G6W4F0V8Z3)
- DATURA STRAMONIUM (UNII: G6W4F0V8Z3) (Active Moiety)
Which are Neurobalance Pro Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- ALCOHOL (UNII: 3K9958V90M)
Which are the Pharmacologic Classes for Neurobalance Pro?
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Adrenocorticotropic Hormone - [CS]
- Adrenocorticotropic Hormone - [EPC] (Established Pharmacologic Class)
- Amino Acids, Aromatic - [CS]
- Aromatic Amino Acid - [EPC] (Established Pharmacologic Class)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cholinergic Agonists - [MoA] (Mechanism of Action)
- Cholinergic Receptor Agonist - [EPC] (Established Pharmacologic Class)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".